Red color represents old content. It may be empty showing addition in the new version.
Green color represents new content. It may be empty showing deletion in the new version.
Inline
Side by side
Added new contents,
deleted old contents,contents that are not changed.
New table contents
New table contents
Old table contents
Old table contents
Unchanged contents
Unchanged contents
Added new contents, contents that are not changed.
Deleted old contents, contents that are not changed.
Old table contents
Old table contents
Unchanged contents
Unchanged contents
New table contents
New table contents
Unchanged contents
Unchanged contents
چکیده پروتکل
double Blind Parallel Arm Study. Randomized Controlled Trial.
Double Blind Parallel Arm Study. Randomized Clinical Trial.
doubleDouble Blind Parallel Arm Study. Randomized ControlledClinical Trial.
This double blind (patient ad outcome assessor will be blinded) parallel assignment study will be conducted in approximately five months at 2 settings;
1- Physiotherapy Department Syed Medical Complex, Sialkot
2- Physiotherapy Department Sialkot College of Physical Therapy, Amin welfare & Teaching Hospital, Sialkot.
This double blind (patient and outcome assessor will be blinded) parallel assignment study will be conducted in approximately one year at 2 settings;
1- Physiotherapy Department Syed Medical Complex, Sialkot Pakistan.
2- Physiotherapy Department Sialkot College of Physical Therapy, Amin Welfare & Teaching Hospital, Sialkot Pakistan.
This double blind (patient adand outcome assessor will be blinded) parallel assignment study will be conducted in approximately five monthsone year at 2 settings; 1- Physiotherapy Department Syed Medical Complex, Sialkot Pakistan. 2- Physiotherapy Department Sialkot College of Physical Therapy, Amin welfareWelfare & Teaching Hospital, Sialkot Pakistan.
Patient Rated Tennis Elbow Evaluation Questionnaire, NPRS and SF-36
Patient Rated Tennis Elbow Evaluation Questionnaire and NPRS
Patient Rated Tennis Elbow Evaluation Questionnaire, NPRS and SF-36NPRS
اطلاعات عمومی
Trial completed
Trial completed.
we included special test, which we used while enrolling the patients and finding their eligibility to be included in the trial. The randomization is not changed but the control group was also another intervention that's why we want to update it as randomized clinical trial instead of randomized control trial.
Trial completed. we included special test, which we used while enrolling the patients and finding their eligibility to be included in the trial. The randomization is not changed but the control group was also another intervention that's why we want to update it as randomized clinical trial instead of randomized control trial.
Both Males and Females.
Age between 30-60 years.
pain in twisting and turning movements of forearm.
Difficulty in holding weight in the affected side and walk.
Range of wrist extension complete but painful
Strength of extensor muscles Grade-IV
Both Males and Females.
Age between 30-60 years.
pain in twisting and turning movements of forearm.
Difficulty in holding weight in the affected side and walk.
Range of wrist extension complete but painful
Strength of extensor muscles Grade-IV
Positive Mill's test.
Positive Cozen's test
Both Males and Females. Age between 30-60 years. pain in twisting and turning movements of forearm. Difficulty in holding weight in the affected side and walk. Range of wrist extension complete but painful Strength of extensor muscles Grade-IV Positive Mill's test. Positive Cozen's test
Patients will be divided into two groups. In Group A (Experimental group) patients will have shock wave treatment and in patients Group B (Control) will have ultrasonic therapy and deep friction massage using coin toss method and allocation sequence will be concealed through sealed envelopes.
Concealment of allocation: will be achieved with sequentially numbered, opaque, sealed, envelopes (SNOSE). SNOSE will be used according to guidelines of Doig and Simpson (25). An independent researcher with no clinical involvement in the trial will make the concealed envelopes. 60 Envelopes will be prepared. Half envelops will contain folded papers with Treatment A written on them and the remaining half will contain folded papers with Treatment B written on them. A carbon paper will be inserted in each envelop with carbon side facing the paper so the allocation sequence, patient name, date of birth of participant and other information can be transferred onto allocation paper inside the envelope. A piece of tin foil is also inserted into envelop so the treatment card cannot be read against light. Envelops will be sealed and signed by the maker. A unique randomized number will be allocated to these envelops and shuffled vigorously. Then the envelops will be arranged sequentially and handed over to another independent researcher. Assessor will pretest the participant and if eligible envelope will be allocated to subject. Therapist will record the information on the envelope and open it afterwards to maintain the concealment. Assessor will record the post treatment findings and another independent analyst will analyze the data. This allocation of concealment will ensure the unpredictability of treatment allocation by investigators and patients.
Patients will be divided into two groups. In Group A (Experimental group) patients will have shock wave treatment and in patients Group B (Experimental group) will have ultrasonic therapy and deep friction massage using coin toss method and allocation sequence will be concealed through sealed envelopes.
Concealment of allocation: will be achieved with sequentially numbered, opaque, sealed, envelopes (SNOSE). SNOSE will be used according to guidelines of Doig and Simpson (25). An independent researcher with no clinical involvement in the trial will make the concealed envelopes. 60 Envelopes will be prepared. Half envelops will contain folded papers with Treatment A written on them and the remaining half will contain folded papers with Treatment B written on them. A carbon paper will be inserted in each envelop with carbon side facing the paper so the allocation sequence, patient name, date of birth of participant and other information can be transferred onto allocation paper inside the envelope. A piece of tin foil is also inserted into envelop so the treatment card cannot be read against light. Envelops will be sealed and signed by the maker. A unique randomized number will be allocated to these envelops and shuffled vigorously. Then the envelops will be arranged sequentially and handed over to another independent researcher. Assessor will pretest the participant and if eligible envelope will be allocated to subject. Therapist will record the information on the envelope and open it afterwards to maintain the concealment. Assessor will record the post treatment findings and another independent analyst will analyze the data. This allocation of concealment will ensure the unpredictability of treatment allocation by investigators and patients.
Patients will be divided into two groups. In Group A (Experimental group) patients will have shock wave treatment and in patients Group B (ControlExperimental group) will have ultrasonic therapy and deep friction massage using coin toss method and allocation sequence will be concealed through sealed envelopes. Concealment of allocation: will be achieved with sequentially numbered, opaque, sealed, envelopes (SNOSE). SNOSE will be used according to guidelines of Doig and Simpson (25). An independent researcher with no clinical involvement in the trial will make the concealed envelopes. 60 Envelopes will be prepared. Half envelops will contain folded papers with Treatment A written on them and the remaining half will contain folded papers with Treatment B written on them. A carbon paper will be inserted in each envelop with carbon side facing the paper so the allocation sequence, patient name, date of birth of participant and other information can be transferred onto allocation paper inside the envelope. A piece of tin foil is also inserted into envelop so the treatment card cannot be read against light. Envelops will be sealed and signed by the maker. A unique randomized number will be allocated to these envelops and shuffled vigorously. Then the envelops will be arranged sequentially and handed over to another independent researcher. Assessor will pretest the participant and if eligible envelope will be allocated to subject. Therapist will record the information on the envelope and open it afterwards to maintain the concealment. Assessor will record the post treatment findings and another independent analyst will analyze the data. This allocation of concealment will ensure the unpredictability of treatment allocation by investigators and patients.